TY  - GEN
AU  - Kubesova,B
AU  - Pavlova,S
AU  - Malcikova,J
AU  - Kabathova,J
AU  - Radova,L
AU  - Tom,N
AU  - Tichy,B
AU  - Plevova,K
AU  - Kantorova,B
AU  - Fiedorova,K
AU  - Slavikova,M
AU  - Bystry,V
AU  - Kissova,J
AU  - Gisslinger,B
AU  - Gisslinger,H
AU  - Penka,M
AU  - Mayer,J
AU  - Kralovics,R
AU  - Pospisilova,S
AU  - Doubek,M
TI  - Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status
SN  - 1476-5551
PY  - 2019///0102
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Alleles
KW  - Disease Progression
KW  - Female
KW  - Gene Frequency
KW  - drug effects
KW  - High-Throughput Nucleotide Sequencing
KW  - methods
KW  - Humans
KW  - Hydroxyurea
KW  - administration & dosage
KW  - Janus Kinase 2
KW  - genetics
KW  - Leukemia, Myeloid, Acute
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Myeloproliferative Disorders
KW  - Retrospective Studies
KW  - Tumor Suppressor Protein p53
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/leu.2017.230
ER  -